Literature DB >> 22280196

Economic burden of hypoglycemia in patients with Type 2 diabetes.

Shuqian Liu1, Yingnan Zhao, James M Hempe, Vivian Fonseca, Lizheng Shi.   

Abstract

Hypoglycemia is an acute complication of diabetes that increases morbidity, mortality and economic costs of diabetes. It presents major clinical problems for the management of Type 2 diabetes as this disease represents the great majority of all diabetes cases. Hypoglycemia makes it difficult for some individuals to achieve good glycemic control, reduces quality of life and increases the burden of diabetes to healthcare systems. Understanding hypoglycemia risk factors can help patients with Type 2 diabetes to correct and avoid hypoglycemia. Recently, an increased risk of hypoglycemia with intensive glycemic control has been identified as an important problem in optimally controlling blood glucose levels in patients with Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280196     DOI: 10.1586/erp.11.87

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  9 in total

1.  Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014.

Authors:  Grace K Mahoney; Henry J Henk; Rozalina G McCoy
Journal:  Mayo Clin Proc       Date:  2019-08-15       Impact factor: 7.616

2.  Hypoglycemia in type 2 diabetes: understanding patients' and physicians' knowledge and experience.

Authors:  Simon J Fisher; Xingyue Huang; Manjiri Pawaskar; Edward A Witt; Swapnil Rajpathak; R Ravi Shankar; Silvio E Inzucchi
Journal:  Endocrine       Date:  2018-02-19       Impact factor: 3.633

3.  Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest.

Authors:  Lucas A Myers; Kristi M Swanson; Amy E Glasgow; Rozalina G McCoy
Journal:  Diabetes Care       Date:  2022-08-01       Impact factor: 17.152

Review 4.  Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies.

Authors:  Richard Silbert; Alejandro Salcido-Montenegro; Rene Rodriguez-Gutierrez; Abdulrahman Katabi; Rozalina G McCoy
Journal:  Curr Diab Rep       Date:  2018-06-21       Impact factor: 4.810

5.  Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.

Authors:  L Tao; E C F Wilson; N J Wareham; A Sandbaek; G E H M Rutten; T Lauritzen; K Khunti; M J Davies; K Borch-Johnsen; S J Griffin; R K Simmons
Journal:  Diabet Med       Date:  2015-04-15       Impact factor: 4.359

6.  Impact of hypoglycemic episodes on health-related quality of life of type-2 diabetes mellitus patients: development and validation of a specific QoLHYPO© questionnaire.

Authors:  Domingo Orozco-Beltrán; Sara Artola; Margarida Jansà; Martin Lopez de la Torre-Casares; Eva Fuster
Journal:  Health Qual Life Outcomes       Date:  2018-03-23       Impact factor: 3.186

7.  Cost of hospitalisation and length of stay due to hypoglycaemia in patients with diabetes mellitus: a cross-sectional study.

Authors:  Abdallah Y Naser; Hassan Alwafi; Zahra Alsairafi
Journal:  Pharm Pract (Granada)       Date:  2020-05-25

8.  Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda
Journal:  Drug Des Devel Ther       Date:  2014-06-18       Impact factor: 4.162

9.  Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea.

Authors:  Gyuri Kim; Yong-Ho Lee; Mi Hye Han; Eui-Kyung Lee; Chong Hwa Kim; Hyuk Sang Kwon; In Kyung Jeong; Eun Seok Kang; Dae Jung Kim
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.